MedTrace Logo

Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury

NCT01215019 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-04-04

No results posted yet for this study

Summary

Osmotic therapy is a mainstay in the treatment of intracranial hypertension after traumatic brain injury.This study proposes to compare two hypertonic saline agents in patients with traumatic brain injury.

Conditions

Interventions

DRUG

Mannitol

20% Mannitol, 1-5 doses as needed to control ICP

DRUG

NaCl

3% sodium chloride injection, 1-5 doses, as needed to control ICP

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Richard B. Rodgers, MD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01215019 on ClinicalTrials.gov